Viewing Study NCT05000892


Ignite Creation Date: 2025-12-24 @ 3:23 PM
Ignite Modification Date: 2026-01-29 @ 2:38 PM
Study NCT ID: NCT05000892
Status: RECRUITING
Last Update Posted: 2022-12-02
First Post: 2021-08-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Salivary Gland Malignant Neoplasms View
None Salivary Gland Tumors View
Keywords: